Related Experiment Video
Updated: Feb 25, 2026
10:31
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
766
[Update on proteomic use in hemodialysis].
Mario Bonomini1, Vittorio Sirolli1, Silvia Baroni2
1Clinica Nefrologica, Università degli Studi "G. d'Annunzio", Chieti-Pescara, Ospedale Clinicizzato "SS. Annunziata", Chieti.
Summary
Proteomics enhances understanding of hemodialysis by defining uremic toxicity and identifying biomarkers. This review covers recent proteomic investigations in chronic hemodialysis therapy, advancing renal replacement therapy research.
Area of Science:
- Biochemistry
- Molecular Biology
- Renal Medicine
Background:
- Proteomics is crucial for understanding protein roles in cell function.
- Proteomic technologies are increasingly used in renal replacement therapy research, specifically hemodialysis.
- Shotgun bottom-up liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) has advanced uremic toxicity research.
Purpose of the Study:
- To review recent proteomic investigations in chronic hemodialysis therapy.
- To highlight the application of proteomics in understanding uremic toxicity.
- To explore the use of proteomics for identifying biomarkers and assessing hemodialysis efficiency and biocompatibility.
Main Methods:
- Application of shotgun bottom-up LC-MS/MS approaches.
- Proteomic investigations in the context of chronic hemodialysis.
- Review of recent scientific literature on proteomics in hemodialysis.
Main Results:
- Discovery of novel uremic toxins.
- Potential for a precise molecular definition of uremia.
- Identification of prognostic biomarkers.
- Testing of blood purification efficiency.
- Assessment of dialyzer membrane biocompatibility.
Conclusions:
- Proteomics offers significant insights into chronic hemodialysis therapy.
- Proteomic approaches are vital for defining uremic toxicity and improving patient outcomes.
- Further proteomic research is essential for advancing renal replacement therapies.
Related Concept Videos
01:25Hemodialysis I: Introduction
2.2K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.2K
01:15Dialysis
2.0K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.0K
01:27Dialysis
1.6K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.6K
01:30Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
639
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
639
01:24Hemodialysis II: Procedure and Complications
1.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.2K
01:20Acute Kidney Injury V: Interprofessional Care
392
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
392